Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accustem Sciences Inc.ACUT · Entity 8467 | Director · 10% owner | June 13, 2025 | June 16, 2025 |
| OKYO Pharma LtdOKYO · Entity 6916 | Director · 10% owner | July 21, 2026 | August 07, 2026 |
| Tiziana Life Sciences LtdTLSA · Entity 6639 | Director · 10% owner | July 21, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accustem Sciences Inc.
Report date June 13, 2025 · Filed June 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectVia Panetta Partners Limited | 6,502,000 |
Reported balance
After 2025-06-13 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-06-13 · Purchase · Acquired 2,000 · Balance 6,502,000 |
| Common StockSEC Table I · non-derivative | IndirectVia Panetta Partners Limited | 6,502,400 |
Reported balance
After 2025-06-13 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-06-13 · Purchase · Acquired 400 · Balance 6,502,400 |
OKYO Pharma Ltd
Report date July 21, 2026 · Filed August 07, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | IndirectVia Panetta Partners Limited | 10,873,916 |
Reported balance
After 2026-07-21 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-07-21 · Purchase · Acquired 22,500 · Balance 10,873,916 |
Tiziana Life Sciences Ltd
Report date July 21, 2026 · Filed August 07, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | IndirectVia Panetta Partners Limited | 44,814,587 |
Reported balance
After 2026-07-21 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-07-21 · Purchase · Acquired 42,357 · Balance 44,814,587 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2026 Filed Jul 23, 2026 20:15 UTC | Tiziana Life Sciences Ltd TLSA · Entity 6639 | GrantCOMMON STOCK | 42,357 | $0.99 | $41,933.43 |
DisclosureSEC source: 0001213900-26-080880 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 44,814,587 Read SEC document |
| July 21, 2026 Filed Jul 23, 2026 20:15 UTC | OKYO Pharma Ltd OKYO · Entity 6916 | GrantCOMMON STOCK | 22,500 | $1.45 | $32,625.00 |
DisclosureSEC source: 0001493152-26-034408 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 10,873,916 Read SEC document |
| July 21, 2026 Filed Aug 7, 2026 20:16 UTC Amendment | Tiziana Life Sciences Ltd TLSA · Entity 6639 | PurchaseCOMMON STOCK | 42,357 | $0.99 | $41,933.43 |
DisclosureSEC source: 0001213900-26-086697 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 44,814,587 Read SEC document |
| July 21, 2026 Filed Aug 7, 2026 20:15 UTC Amendment | OKYO Pharma Ltd OKYO · Entity 6916 | PurchaseCOMMON STOCK | 22,500 | $1.45 | $32,625.00 |
DisclosureSEC source: 0001493152-26-036579 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 10,873,916 Read SEC document |
| July 20, 2026 Filed Jul 21, 2026 20:15 UTC | OKYO Pharma Ltd OKYO · Entity 6916 | GrantCOMMON STOCK | 25,000 | $1.40 | $35,000.00 |
DisclosureSEC source: 0001493152-26-034084 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 10,851,416 Read SEC document |
| July 20, 2026 Filed Aug 7, 2026 20:15 UTC Amendment | OKYO Pharma Ltd OKYO · Entity 6916 | PurchaseCOMMON STOCK | 25,000 | $1.40 | $35,000.00 |
DisclosureSEC source: 0001493152-26-036582 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 10,851,416 Read SEC document |
| June 12, 2026 Filed Jun 17, 2026 10:31 UTC | Tiziana Life Sciences Ltd TLSA · Entity 6639 | GrantCOMMON STOCK | 15,000 | $1.11 | $16,650.00 |
DisclosureSEC source: 0001213900-26-069424 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 44,772,230 Read SEC document |
| June 12, 2026 Filed Aug 7, 2026 20:15 UTC Amendment | Tiziana Life Sciences Ltd TLSA · Entity 6639 | PurchaseCOMMON STOCK | 15,000 | $1.11 | $16,650.00 |
DisclosureSEC source: 0001213900-26-086696 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 44,772,230 Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:30 UTC | OKYO Pharma Ltd OKYO · Entity 6916 | GrantCOMMON STOCK | 300,000 | $1.72 | $516,000.00 |
DisclosureSEC source: 0001493152-26-028117 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 10,826,416 Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 14:22 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 400 | $1.10 | $440.00 |
DisclosureSEC source: 0001641172-25-015197 · ownership.xml · nonDerivative · entry 2 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 6,502,400 Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 14:22 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 2,000 | $1.00 | $2,000.00 |
DisclosureSEC source: 0001641172-25-015197 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 6,502,000 Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 14:26 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 8,991 | $0.83 | $7,462.53 |
DisclosureSEC source: 0001641172-25-015003 · ownership.xml · nonDerivative · entry 2 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 6,500,000 Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 14:26 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 28,205 | $0.39 | $10,999.95 |
DisclosureSEC source: 0001641172-25-015003 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 6,491,009 Read SEC document |
| April 09, 2025 Filed Apr 10, 2025 20:15 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 3,000 | $0.67 | $2,010.00 |
DisclosureSEC source: 0001641172-25-003618 · ownership.xml · nonDerivative · entry 2 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 4,910,759 Read SEC document |
| April 08, 2025 Filed Apr 10, 2025 20:15 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 35,000 | $0.67 | $23,275.00 |
DisclosureSEC source: 0001641172-25-003618 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 4,907,759 Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:15 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 35,000 | $0.65 | $22,750.00 |
DisclosureSEC source: 0001641172-25-003222 · ownership.xml · nonDerivative · entry 3 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 4,872,759 Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:15 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 17,802 | $0.61 | $10,841.42 |
DisclosureSEC source: 0001641172-25-003222 · ownership.xml · nonDerivative · entry 2 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 4,837,759 Read SEC document |
| March 18, 2025 Filed Apr 8, 2025 20:15 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 100,000 | $0.45 | $44,700.00 |
DisclosureSEC source: 0001641172-25-003222 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 4,819,957 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 19:06 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 100,000 | $0.38 | $38,100.00 |
DisclosureSEC source: 0001493152-25-000211 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 4,719,957 Read SEC document |
| October 27, 2023 Filed Oct 31, 2023 20:15 UTC | OKYO Pharma Ltd OKYO · Entity 6916 | OtherOrdinary Shares | 70,071 | $1.50 | $105,106.50 |
DisclosureSEC source: 0001493152-23-038854 · ownership.xml · nonDerivative · entry 2 CERRONE GABRIELE M · CIK 0001139306 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 9,177,903 F2 · kind: Represents ordinary shares issued in lieu of cash payment to the Reporting Person. Read SEC document |
| October 23, 2023 Filed Oct 31, 2023 20:15 UTC | OKYO Pharma Ltd OKYO · Entity 6916 | OtherOrdinary Shares | 499,468 | $1.50 | $749,202.00 |
DisclosureSEC source: 0001493152-23-038854 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 9,107,832 F1 · kind: Represents ordinary shares received in satisfaction of bonus Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 16:25 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 5,000 | $1.40 | $7,000.00 |
DisclosureSEC source: 0001493152-23-000064 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited and Planwise Group Limited Disclosed balance after: 3,864,452 Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 11:15 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 3,729 | $1.42 | $5,295.18 |
DisclosureSEC source: 0001493152-22-034396 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited and Planwise Group Limited Disclosed balance after: 3,859,452 Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 13:00 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 24,500 | $1.05 | $25,725.00 |
DisclosureSEC source: 0001493152-22-033239 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited and Planwise Group Limited Disclosed balance after: 3,855,723 Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 13:41 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 10,000 | $0.79 | $7,900.00 |
DisclosureSEC source: 0001493152-22-020942 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited and Planwise Group Limited Disclosed balance after: 3,831,223 Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 16:26 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 20,000 | $0.50 | $10,000.00 |
DisclosureSEC source: 0001493152-22-016256 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited and Planwise Group Limited Disclosed balance after: 3,821,226 Read SEC document |
| May 19, 2022 Filed May 19, 2022 15:14 UTC | OKYO Pharma Ltd OKYO · Entity 6916 | PurchaseAmerican Depositary Shares | 37,500 | $4.00 | $150,000.00 |
DisclosureSEC source: 0001493152-22-014437 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · Non-Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 62,500 Read SEC document |
| May 19, 2022 Filed May 20, 2022 14:35 UTC | OKYO Pharma Ltd OKYO · Entity 6916 | PurchaseOrdinary Shares | 5,800,000 | $0.08 | $440,800.00 |
DisclosureSEC source: 0001493152-22-014552 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 548,981,215 Read SEC document |
| May 17, 2022 Filed May 18, 2022 17:38 UTC Amendment | OKYO Pharma Ltd OKYO · Entity 6916 | PurchaseAmerican Depositary Shares | 25,000 | $3.87 | $96,750.00 |
DisclosureSEC source: 0001493152-22-014299 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · Non-Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 25,000 Read SEC document |
| May 17, 2022 Filed May 18, 2022 15:37 UTC | OKYO Pharma Ltd OKYO · Entity 6916 | PurchaseOrdinary Shares | 1,625,000 | $0.06 | $96,687.50 |
DisclosureSEC source: 0001493152-22-014284 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · Non-Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited Disclosed balance after: 544,806,215 Read SEC document |
| April 26, 2022 Filed Apr 27, 2022 18:29 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 5,266 | $1.49 | $7,846.34 |
DisclosureSEC source: 0001493152-22-011318 · ownership.xml · nonDerivative · entry 2 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited and Planwise Group Limited Disclosed balance after: 3,801,226 Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:29 UTC | Accustem Sciences Inc. ACUT · Entity 8467 | PurchaseCommon Stock | 4,181 | $1.35 | $5,644.35 |
DisclosureSEC source: 0001493152-22-011318 · ownership.xml · nonDerivative · entry 1 CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Via Panetta Partners Limited and Planwise Group Limited Disclosed balance after: 3,795,960 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.